Premalignant colorectal polyps less likely in aspirin and NSAID users -- UNC study.
This article was originally published in The Tan Sheet
Executive Summary
PREMALIGNANT COLORECTAL POLYPS LESS LIKELY IN ASPIRIN, NSAID USERS than nonusers, a study of 379 patients published in the March issue of Gastroenterology finds. "In summary, we found that premalignant colorectal adenomas were less likely among individuals who regularly consumed aspirin and nonsteroidal anti-inflammatory agents," Robert Sandler, MD, et al., University of North Carolina, state. The study was funded in part by grants from the National Institutes of Health. Adenomas are precursors to most types of colorectal cancer.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning